Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dicerna Pharmaceuticals Inc (DRNA)

  7. Dicerna Pharmaceuticals Inc (DRNA) Financials

DRNA

Dicerna Pharmaceuticals Inc

38.22
0.00 (0.0%)
Upgrade to Real-Time

Dicerna Pharmaceuticals Inc. (DRNA) Fundamentals
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, cardiovascular diseases, cancers, and other liver problems. The company uses its ribonucleic acid interference technology platform to develop its products. In addition, Dicerna's proprietary GalXC technology focuses on silencing disease-causing genes. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others. Dicerna generates revenue by forming collaborative relationships with pharmaceutical companies such as Eli Lilly, Roche, Novo Nordisk, and others.
SHARE INFORMATION
Market Cap$ 2,977,701,510
Shares Outstanding77,909,511
Float74,678,615
Percent Float95.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 146,227,233
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2020-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions504
Institutional Holdings Date2021-12-31
Institutional Bought Previous 3 Months8,841,478
Institutional Holdings Percent92.7%
Institutional Sold Previous 3 Months20,621,624
Insider Holdings Date2021-12-31
Insider Bought Previous 3 Months245,831
Insider Holdings Percent0.2
Insider Sold Previous 3 Months9,870,598
Insider Shares Owned183,067
TRADING INFO
52 Week High$ 40.14
52 Week Low$ 19.06
52 Week High Change$ 71.54
21 Day Moving Average$ 38.0414
21 Day Extended Moving Average$ 36.6529
50 Day Moving Average$ 30.4182
50 Day Extended Moving Average$ 32.3734
200 Day Moving Average$ 28.7308
200 Day Extended Moving Average$ 28.0365
10 Day Average Volume3,110,755
20 Day Average Volume3,123,340
30 Day Average Volume4,986,402
50 Day Average Volume3,295,121
Alpha0.053121
Beta0.7860
Standard Deviation0.215473
R20.026058
7 Day Price Change$ 0.22
7 Day Percent Change0.58%
21 Day Price Change$ 0.06
21 Day Percent Change0.16%
30 Day Price Change$ 0.23
30 Day Percent Change0.61%
Month to Date Price Change$ 0.21
Month to Date Percent Change0.55%
Quarter to Date Price Change$ 18.06
Quarter to Date Percent Change89.58%
180 Day Price Change$ 1.67
180 Day Percent Change4.57%
200 Day Price Change$ 0.86
200 Day Percent Change2.3%
Year to Date Price Change$ 16.19
Year to Date Percent Change73.49%

Dicerna Pharmaceuticals Inc. (DRNA) Key Ratios

PROFITABILITY
EBIT Margin-63.8%
EBITDA Margin-61.5%
Pre-Tax Profit Margin-943.4%
Profit Margin Count-28.82%
Gross Margin0.0%
Profit Margin TOT-28.82%
INCOME STATEMENTS
Revenue$ 61,119,594
Revenue Per Share$ 0.7823
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book28.30
Total Debt To Equity0.60
Int Coverage-7,318.90
Current Ratio2.50
Leverage Ratio7.20
Quick Ratio2.40
Long Term Debt To Capital0.36
VALUATION MEASURES
PE Ratio-25.30
Enterprise Value$ 2,186,043,947
Price to Sales48.8568
Price to Free Cash-50.00
PE High Last 5 Years-3.60
Price To Book27.10
Price To Cash Flow136.30
PE Low Last 5 Years-6.70
Price to Tangible Book28.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.20
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-17.22
Return on Equity-95.94
Return on Capital-72.29

Dicerna Pharmaceuticals Inc. (DRNA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEODouglas M. Fambrough
Employees302
Last AuditUQ
CIK0001399529
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address75 Hayden Avenue
Lexington, MA 2421
Websitehttps://www.dicerna.com
Facsimile+1 617 612-6298
Telephone+1 617 621-8097
Email-


Your Recent History
NASDAQ
DRNA
Dicerna Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.